CONMED Corporation

Equities

CNMD

US2074101013

Medical Equipment, Supplies & Distribution

Market Closed - Nyse 04:00:02 2024-03-28 pm EDT 5-day change 1st Jan Change
80.08 USD -0.07% Intraday chart for CONMED Corporation +5.24% -26.87%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
CONMED Corporation Declares Quarterly Cash Dividend, Payable on April 5, 2024 CI
Sector Update: Health Care Stocks Rise in Late Afternoon MT
CONMED Shares Fall After Q4 Results Trail Analyst Estimates MT
Needham Adjusts Price Target on CONMED to $129 From $119, Maintains Buy Rating MT
JPMorgan Cuts CONMED Price Target to $115 From $135, Maintains Overweight Rating MT
CONMED Q4 Adjusted Earnings, Net Sales Rise; Sets 2024 Outlook; Shares Drop MT
Transcript : CONMED Corporation, Q4 2023 Earnings Call, Jan 31, 2024
CONMED Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Earnings Flash (CNMD) CONMED CORPORATION Posts Q4 Revenue $327M, vs. Street Est of $332.2M MT
CONMED Corporation Provides Financial Guidance for the Full Year 2024 CI
CONMED Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Transcript : CONMED Corporation Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-08-2024 02:15 PM
Conmed Insider Sold Shares Worth $252,833, According to a Recent SEC Filing MT
CONMED Keeps Quarterly Dividend at $0.20 a Share, Payable Jan. 5 to Shareholders of Record Dec. 18 MT
CONMED Corporation Announces Quarterly Cash Dividend, Payable on January 5, 2024 CI
Conmed Insider Sold Shares Worth $122,874, According to a Recent SEC Filing MT
Piper Sandler Adjusts Price Target on CONMED to $130 From $145, Maintains Overweight Rating MT
Wells Fargo Cuts Price Target on CONMED to $107 From $123, Maintains Equalweight Rating MT
Tranche Update on CONMED Corporation's Equity Buyback Plan announced on February 15, 2005. CI
Conmed's Q3 Adjusted Earnings, Sales Rise; Raises Low End of 2023 Outlook Range MT
Transcript : CONMED Corporation, Q3 2023 Earnings Call, Oct 25, 2023
Earnings Flash (CNMD) CONMED CORPORATION Reports Q3 Revenue $304.6M, vs. Street Est of $301.4M MT
CONMED Corporation Updates Third Quarter Guidance for 2023 CI
CONMED Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
CONMED Corporation Announces Quarterly Cash Dividend, Payable on October 5, 2023 CI
Chart CONMED Corporation
More charts
CONMED Corporation is a medical technology company, which provides surgical devices and equipment for minimally invasive procedures. Its products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. Its product lines consist of orthopedic surgery and general surgery. Orthopedic surgery consists of sports medicine and lower extremities instrumentation and implants, small bone, large bone, and specialty powered surgical instruments as well as imaging systems for use in minimally invasive surgery procedures and fees related to the sales representation, promotion, and marketing of sports medicine allograft tissue. General surgery consists of endo-mechanical instrumentation for minimally invasive laparoscopic and gastrointestinal procedures, smoke evacuation devices, a line of cardiac monitoring products as well as electrosurgical generators and related instruments.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
80.08 USD
Average target price
111.1 USD
Spread / Average Target
+38.77%
Consensus
  1. Stock
  2. Equities
  3. Stock CONMED Corporation - Nyse
  4. News CONMED Corporation
  5. CONMED Proposes Private Offering of $600 Million Convertible Senior Notes